Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Cullen

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
The Canadian Journal of Urology|August 31, 2019
A prospective study of health-related quality of life outcomes among men treated for intermediate- and high-risk prostate cancer: the impact of primary and secondary therapiesMazen Alsinnawi, Jennifer Cullen, Lauren M Hurwitz, et al.
Cancers|March 4, 2026
RETRACTED: Sharad et al. Analysis of <i>PMEPA1</i> Isoforms (<i>a</i> and <i>b</i>) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer. <i>Cancers</i> 2019, <i>11</i>, 1995Shashwat Sharad, Zsófia M Sztupinszki, Yongmei Chen, et al.
Cancers|December 18, 2019
Analysis of <i>PMEPA1</i> Isoforms (<i>a</i> and <i>b</i>) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate CancerShashwat Sharad, Zsófia M Sztupinszki, Yongmei Chen, et al.
Clinical Genitourinary Cancer|September 19, 2019
PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical ProstatectomyMark C Markowski, Yongmei Chen, Zhaoyong Feng, et al.
The Journal of Urology|September 20, 2008
PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volumeEric J Whitman, Jack Groskopf, Amina Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survivalJoseph R Sterbis, Chunling Gao, Bungo Furusato, et al.
The Journal of Urology|September 18, 2020
A Urine Exosome Gene Expression Panel Distinguishes between Indolent and Aggressive Prostate Cancers at BiopsyIndu Kohaar, Yongmei Chen, Sreedatta Banerjee, et al.
European Urology Oncology|May 11, 2024
Assessing the Clinical Utility of Published Prostate Cancer Polygenic Risk Scores in a Large Biobank Data SetRandy A Vince, Helen Sun, Udit Singhal, et al.
The Journal of Urology|March 16, 2016
Prospective Quality of Life in Men Choosing Active Surveillance Compared to Those Biopsied but not Diagnosed with Prostate CancerKhanh N Pham, Jennifer Cullen, Lauren M Hurwitz, et al.
Urology|May 31, 2022
AUTHOR REPLYJacob M Knorr, Rebecca A Campbell, Joshua Cockrum, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
The Canadian Journal of Urology|August 31, 2019
A prospective study of health-related quality of life outcomes among men treated for intermediate- and high-risk prostate cancer: the impact of primary and secondary therapiesMazen Alsinnawi, Jennifer Cullen, Lauren M Hurwitz, et al.
Cancers|March 4, 2026
RETRACTED: Sharad et al. Analysis of <i>PMEPA1</i> Isoforms (<i>a</i> and <i>b</i>) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer. <i>Cancers</i> 2019, <i>11</i>, 1995Shashwat Sharad, Zsófia M Sztupinszki, Yongmei Chen, et al.
Cancers|December 18, 2019
Analysis of <i>PMEPA1</i> Isoforms (<i>a</i> and <i>b</i>) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate CancerShashwat Sharad, Zsófia M Sztupinszki, Yongmei Chen, et al.
Clinical Genitourinary Cancer|September 19, 2019
PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical ProstatectomyMark C Markowski, Yongmei Chen, Zhaoyong Feng, et al.
The Journal of Urology|September 20, 2008
PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volumeEric J Whitman, Jack Groskopf, Amina Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survivalJoseph R Sterbis, Chunling Gao, Bungo Furusato, et al.
The Journal of Urology|September 18, 2020
A Urine Exosome Gene Expression Panel Distinguishes between Indolent and Aggressive Prostate Cancers at BiopsyIndu Kohaar, Yongmei Chen, Sreedatta Banerjee, et al.
European Urology Oncology|May 11, 2024
Assessing the Clinical Utility of Published Prostate Cancer Polygenic Risk Scores in a Large Biobank Data SetRandy A Vince, Helen Sun, Udit Singhal, et al.
The Journal of Urology|March 16, 2016
Prospective Quality of Life in Men Choosing Active Surveillance Compared to Those Biopsied but not Diagnosed with Prostate CancerKhanh N Pham, Jennifer Cullen, Lauren M Hurwitz, et al.
Urology|May 31, 2022
AUTHOR REPLYJacob M Knorr, Rebecca A Campbell, Joshua Cockrum, et al.
Pageof 17